POSTER TITLE: CLINICAL AND RADIOLOGICAL PROFILE, TREATMENT AND OUTCOME OF PEDIATRIC ACQUIRED DEMYELINATING DISORDERS OF CENTRAL NERVOUS SYSTEM PRESENTER.

Slides:



Advertisements
Similar presentations
A&P Signs & Symptoms Management of condition
Advertisements

DEMYELINATING DISEASES (MULTIPLE SCLEROSIS)
Devic’s neuromyelitis optica: its distinctive features and treatment
Distinguishing Devic's neuromyelitis optica from multiple sclerosis: a case report. Jeff S. Berger, DO, Ian B. Maitin, MD, MBA Department of Physical Medicine.
Overview of Multiple Sclerosis  Valerie Robinson, D.O. 
Transverse Myelitis Emily O. Jenkins MD, PGY3 AM Report
VIRAL ENCEPHALITIS A range of viruses can cause encephalitis but only a minority of patients have a history of recent viral infection. In Europe, the most.
Challenges in Diagnosing MS. An MS diagnosis requires evidence of dissemination in both space and time. Which of the following would not constitute evidence.
Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.
MULTIPLE SCLEROSIS In multiple sclerosis, one of the most common neurological causes of long-term disability, the myelin-producing oligodendrocytes of.
Cahalans-Month-of-Madness/
Poster Title Author(s) Institution Poster Title Author(s) Institution INTRODUCTION HISTORY SIMSCON th South Indian Medical Students’ Conference,
Multiple Sclerosis. Inflammatory demyelinating disease of the central nervous system. Most common cause of neurological disability in young adults.
Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology A 51-year-old woman with triplegia and blindness.
Multiple Sclerosis Rohith M. Reddy. Multiple sclerosis (MS) involves an immune-mediated process in which an abnormal response of the body’s immune system.
CONTRIBUTION OF MRI IN SERIOUS FORMS OF ACUTE DISSEMINATED ENCEPHALOMYELITIS AND POST INFECTIOUS HERPES ENCEPHALITIS M.OMRI, W.HIZEM-HARZALLAH, Z.ABOUZARIFA,
Aseptic meningitis  definition: When the CSF culture was negative.  CSF: pressure mmh2o: normal or slightly elevated. leukocytes : PMN early mononuclear.
Initial presentation of multiple sclerosis in northern Iran; Is there any comparison to other countries Initial presentation of multiple sclerosis in northern.
V V ISOLATED BRAINSTEM SYNDROME AS THE SOLE MANIFESTATION OF NEUROMYELITIS OPTICA SPECTRUM DISORDER Gisele O. Lima, Natália C. Talim 1, Lívia E. C. Talim.
Jason Chiang, MD, PhD & Clayton Wiley, MD, PhD University of Pittsburgh Medical Center Department of Pathology Division of Neuropathology.
Salient Features: SUBJECTIVE
Sagittal FLAIR images - Stable nonenhancing hyperintensities within the pericallosal white matter and bilateral centrum semiovale, consistent with known.
Adult Medical-Surgical Nursing Neurology Module: Multiple Sclerosis.
Practical Management of MS in the Primary Care Office Setting Case Study 1.
Int J MS Care 7: , 2005/2006. Jan 9 & 10, Clinical Stabilization of a MS Patient after Tonsillectomy presented by Michael C. Levin, MD Department.
Clinical features, disease course and prognosis in patients with paediatric And young adult onset multiple sclerosis. Paolo Ragonese, Maria Antonietta.
Clinico-Radiological Profile of Spinal Cord Multiple Sclerosis Glenn H. Roberson Bhavik N. Patel Asim K. Bag University of Alabama at Birmingham, Birmingham,
Case Report Our patient is a 16 y/o Latin American girl referred from an outside hospital for symptoms of left flank pain radiating to the left lower leg.
Magnetic Resonance Imaging In Young Patients With Neuro - Psychiatric SLE : A Case Series Dr. Vivek Gupta Department of Radiodiagnosis Postgraduate Institute.
Date of download: 6/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Short Myelitis Lesions in Aquaporin-4-IgG–Positive.
Demyelinating Disorders
Multiple sclerosis – late onset. Authors: Vitalie Vacaras Vitalie Vacaras Damian Popescu Damian Popescu Radu Antonescu Radu Antonescu Anca Simu Anca Simu.
Yael Hacohen, Kshitij Mankad, W
Neuromyelitis Optica: Looking at the Brain for Clues
Status Epilepticus Presenting After Traumatic Brain Injury in Infants Kurz, J. E.1; Zelleke, T.1; Carpenter, J.1; Dean, N.2; Singh, J.1; Kadom, N.3; Gaillard,
OPTIC NEURITIS DR ADNAN.
Multiple sclerosis.
Tumefactive rebound of Multiple Sclerosis following cessation of Fingolimod   Sharfaraz Salam, Daniel Dunbar, Tim Lavin, Adrian Pace, Tatiana Mihalova.
Multiple Sclerosis.
DR. SADIK AL-GHAZAWI CONSULTANT NEUROLOGIST MRCP, FRCP UK.
Neuro-ophthalmology.
CNS DEMYELINATING DISEASES (MULTIPLE SCLEROSIS)
Figure 1 An example of individual prediction of response to interferon β-1a and natalizumab in moderately advanced, active multiple sclerosis. Six treatment.
COHORT OF LIMB GIRDLE MUSCULAR DYSTROPHY FROM SOUTHERN INDIA
Differential Diagnosis of Transverse Myelitis Maureen A
Therapeutic plasma exchange in children with acute autoimmune central nervous system disorders Agnieszka Prytuła (1), Johan Vande Walle.
Figure 2. MRI features of patients with MS who had antibodies to myelin oligodendrocyte glycoprotein MRI features of patients with MS who had antibodies.
A 22 year old woman with progressive vision loss
3.02 Understand the functions and disorders of the nervous system
Nat. Rev. Neurol. doi: /nrneurol
Figure 4 Neuromyelitis optica spectrum disorder brain lesions
Seronegative Neuromyelitis Optica: A Case Report of a Hispanic Male
Figure 1 Percent positivity by clinical feature Overall, 6
Figure 2 Temporal distribution of MOG antibody in serum of 2 relapsing patients with demyelinating diseases Temporal distribution of MOG antibody in serum.
Figure 2 NMDAR-Ab levels, clinical syndromes, and therapy in 8 informative patients with white matter syndromes in association with NMDAR-Ab NMDAR-Ab levels,
Pediatric Multiple Sclerosis: The Dawn of a New Era?
Figure 2 Concordance of results for commercial cell-based assay (CBA) and fluorescence-activated cell sorting (FACS) assays, FACS titers, and disease activity.
Typical imaging findings.
Figure 2 Representative brain MRIs from patients with neuromyelitis optica Lesions are localized at sites of high aquaporin-4 expression (white dots).
A Curious Case of NMO Transverse Myelitis – Mystery Solved. Anna M
Figure 4 Confirmatory cohorts to assess MOG-IgG1 assay(A) All 81 aquaporin-4 (AQP4)- seropositive patients (blue) from the Oxford National neuromyelitis.
Figure 1 Kaplan-Meier estimation of time to neuromyelitis optica (NMO) conversion and development of motor disability Kaplan-Meier estimation of time to.
3.02 Understand the functions and disorders of the nervous system
Figure 1 Distribution of MOG IgG antibody in pediatric demyelinating diseases Distribution of MOG IgG antibody in pediatric demyelinating diseases (A)
Figure 1 Relapse and rituximab historyThe figure shows rituximab (RTX) treatment history as well as relapse history for 100 days prior to the first RTX.
Figure Overview of patients with demyelinating diseases, presence of clinical symptoms frequently associated with NMDAR encephalitis, and antibody status.
Figure 1 Radiologic features of patients with white matter syndromes in association with NMDA receptor antibodies Radiologic features of patients with.
Figure 2 Summary of the utility of MOG-Abs and OCB testing in predicting pediatric disease course at onset compared to clinical follow-up at 1 yearFollowing.
Figure 1 Representative spinal cord MRIs from patients with neuromyelitis optica Longitudinally extensive transverse myelitis of the cervical (A) and cervicothoracic.
Figure 1 Full-length MOG cell-based assay using a serum dilution of 1:160 as a cutoff for positivity (red line in both plots)(A) Myelin olidgodendrocyte.
Presentation transcript:

POSTER TITLE: CLINICAL AND RADIOLOGICAL PROFILE, TREATMENT AND OUTCOME OF PEDIATRIC ACQUIRED DEMYELINATING DISORDERS OF CENTRAL NERVOUS SYSTEM PRESENTER NAME:Deepthi Shetty, Vykuntaraju K Gowda, Basavaraj GV, Naveen Benakappa, Asha Benakappa INTRODUCTION AND KEYWORD:Demyelinating disorders are rare childhood disorders. These include acute disseminated encephalomyelitis(ADEM), Multiple sclerosis(MS), Transverse myelitis, optic neuritis and Neuromyelitis optica. These disorders culminate in various physical and cognitive disabilities. Timely diagnosis and institution of appropriate treatment determines prognosis and outcome. KEYWORDS: Demelinating disorders, ADEM, Multiple sclersois, Transverse myelitis, Optic neuritis, Neuromyelitis optica AIM:To study clinical profile, investigative and radiological features, treatment and outcome of children with demyelinating disorders. MATERIALS AND METHODS:A retrospective chart review of children with demyelinating disorder admitted in tertiary care pediatric hospital of Bangalore between Jan 2013 and Aug 2016. Demographic data, clinical features, CSF findings, radiological features, treatment received and outcome were collected and results analysed. RESULTS: Among 26 patients of demyelinating disorders, majority were ADEM-13(50%), followed by transverse myelitis-7 (26.92%), multiple sclerosis 3 (11.54%), optic neuritis- 2 (7.69%) and NMO- 1 (3.85%). Median age of presentation was 8.5years. Among 26 patients, 12 were male (46.15%). In ADEM, median age was 6 years. Among 13 patients, 12(92.13%) had pyramidal features like hemiparesis(6/12, 50%) with or without facial palsy, quadriparesis(4/12, 33.3%) with or without facial palsy and paraparesis(2/12, 16.6%). Encephalopathy was seen at presentation in 10 (76.92%) patients, during hospital stay all patients developed encephalopathy. Convulsion was present in 4 patients(30.77%), neurogenic bladder in 3 patients(23%), sensory involvement in 2(15.38%) patients. CSF analysis was done in 9 patients, which was found to be normal in 4 patients and abnormal in 5 patients ( i.e.,pleocytosis, increased protein). MRI brain done shows hyperintensities in subcortical white matter of supratentorial region, basal ganglia, thalamus, cerebellum, corpus callosum, cervical- thoracic cord. Basal ganglia involvement was found in 5 (41.6%) patients and spinal cord involvement in 2 (11.6%) patients. Two patients had Tumefactive ADEM. 10 recovered with residual disability in 3 patients after steroid therapy. In MS, median age was 9 years, 2 were female, . Fever preceded most of the events in all 3 with encephalopathy in all 3 patients during acute events( during 1st episode in 2 patients and during 2nd episode in other patient). Other features include convulsions(2/3, 66.67%), left hemiparesis(2/3, 66.67%), meningism(2/3, 66.67%), neurogenic bladder(1/3, 33.33%), paresthesia(1/3). Eye involvement was seen in 2 patients. Recurrent history present in all 3 patients. CSF pleocytosis with positivity for oligoclonal bands is seen in 1 patient. MRI brain done shows multiple demyelinating plaques involving supratentorial, infratentorial, corpus callosum, cerebellum, brainstem, cervical cord with new lesions in repeat MRI. 1 patient died and 2 patients improved. In transverse myelitis, median age was 11 years. 5 had cervical and 2 thoracic cord involvement. . Neurogenic bladder present in all patients , sensory disturbances in 4(57.14%) patients. 6 patients recovered with 1 death. A patient with NMO presented with headache and diminution of vision. , CSF was positive for antibody to aquaporin 4. Child improved with steroids and IVIG. Two patients with optic neuritis presented with headache and diminution of vision. were treated with steroids and they recovered. CONCLUSION:Demyelinating disorders are not uncommon in children. Most common is ADEM. Multiple sclerosis is not rare in children, accounting for 11% in present study. Early diagnosis and treatment with steroids improves outcome. REFERENCES: Michael Absoud, Carole cummins, Christian De Goede, Katharine Foster, Roxanna Gunny et al. Pediatric UK demyelinating disease longitudinal study(PUDDLS). BMC Pediatrics 2011, 11:68 Shelfali Gulati, Biswaroop Chakrabarty, Atin Kumar, Puneet Jain et al. Acquired demyelinating disorders of central nervous system: A pediatric cohort. Ann Indian Acad Neurol. 2015 Sep; 18(Suppl 1): S48-S55 Mahesh Kamate, Vivek Chetal, Venkatesh Tonape, Niranjana Mahantshetti, Virupakshi Hattiholi. Central nervous system inflammatory demyelinating disorders of childhood. Ann Indian Acad Neurol. 2010 Oct-Dec; 13(4): 289-292